Patents Assigned to RXCELL INC.
  • Patent number: 12180510
    Abstract: Methods and compositions for rapid development of reporter lines utilizing safe harbor sites in iPSCS, as well as other progenitor cells, pluripotent and multipotent stem cells and differentiated cells, and multiple Lox sites are provided.
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: December 31, 2024
    Assignee: RxCell Inc.
    Inventors: Xianmin Zeng, Mahendra S. Rao
  • Patent number: 11530389
    Abstract: Methods and compositions for rapid development of reporter lines utilizing safe harbor sites in iPSCS, as well as other progenitor cells, pluripotent and multipotent stem cells and differentiated cells, and multiple Lox sites are provided.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: December 20, 2022
    Assignee: RXCELL INC.
    Inventors: Xianmin Zeng, Mahendra S. Rao
  • Patent number: 10787644
    Abstract: Methods and compositions for rapid development of reporter lines utilizing safe harbor sites in iPSCS, as well as other progenitor cells, pluripotent and multipotent stem cells and differentiated cells, and multiple Lox sites are provided.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: September 29, 2020
    Assignee: RXCELL INC.
    Inventors: Xianmin Zeng, Mahendra S. Rao